Showing results (111-120 of 187) with videos related to

Sort By:
Pageof 19
Molecular Human Reproduction|January 5, 2002
Polymorphisms of the angiotensinogen gene, the endothelial nitric oxide synthase gene, and the interleukin-1beta gene promoter in women with idiopathic recurrent miscarriageLukas A Hefler, Clemens B Tempfer, Michael T Bashford, et al.
Gynecologic Oncology|June 16, 2004
Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancerEva-Katrin Riener, Lukas A Hefler, Christoph Grimm, et al.
Gynecologic Oncology|March 14, 2018
Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortiumJohanna M Gostner, Eva Obermayr, Ioana E Braicu, et al.
Oncology Letters|June 8, 2017
Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancerFelicitas Mungenast, Stefanie Aust, Ignace Vergote, et al.
Disease Markers|December 20, 2008
Circulating cell-free DNA in plasma of locally advanced rectal cancer patients undergoing preoperative chemoradiation: a potential diagnostic tool for therapy monitoringMatthias Zitt, Hannes M Müller, Marina Rochel, et al.
International Journal of Cancer|July 13, 2002
Expression of MUC1 splice variants in benign and malignant ovarian tumoursAndreas Obermair, Bernd C Schmid, Leisl M Packer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5Peter Horak, Dietmar Pils, Alexandra Kaider, et al.
Oncology Reports|July 20, 2011
Basal-like molecular subtype and HER4 up-regulation and response to neoadjuvant chemotherapy in breast cancerElmar Stickeler, Dietmar Pils, Maximilian Klar, et al.
Cancers|January 11, 2022
tRNA<sup>GlyGCC</sup>-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and ProgressionKonstantina Panoutsopoulou, Tobias Dreyer, Julia Dorn, et al.
Gynecologic Oncology|September 29, 2012
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortiumEva Obermayr, Dan Cacsire Castillo-Tong, Dietmar Pils, et al.
Pageof 19